Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Stroke

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 70 articles:
HTML format



Single Articles


    November 2022
  1. RAISI-ESTABRAGH Z, Cooper J, Bethell MS, McCracken C, et al
    Lower birth weight is linked to poorer cardiovascular health in middle-aged population-based adults.
    Heart. 2022 Nov 16. pii: heartjnl-2022-321733. doi: 10.1136/heartjnl-2022-321733
    PubMed     Abstract available


    October 2022
  2. CASO V, de Groot JR, Sanmartin Fernandez M, Segura T, et al
    Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2022 Oct 31. pii: heartjnl-2022-321114. doi: 10.1136/heartjnl-2022-321114
    PubMed     Abstract available


  3. RAISI-ESTABRAGH Z, Cooper J, Salih A, Raman B, et al
    Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank.
    Heart. 2022 Oct 24. pii: heartjnl-2022-321492. doi: 10.1136/heartjnl-2022-321492
    PubMed     Abstract available


  4. THALMANN I, Preiss D, Schlackow I, Gray A, et al
    Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009-2017.
    Heart. 2022 Oct 3. pii: heartjnl-2022-321452. doi: 10.1136/heartjnl-2022-321452.
    PubMed     Abstract available


    July 2022
  5. KANY S, Cardoso VR, Bravo L, Williams JA, et al
    Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank.
    Heart. 2022 Jul 14. pii: heartjnl-2022-321196. doi: 10.1136/heartjnl-2022-321196
    PubMed     Abstract available


  6. KIM HJ, Chang DH, Kim SO, Kim JK, et al
    Left atrial appendage preservation versus closure during surgical ablation of atrial fibrillation.
    Heart. 2022 Jul 13. pii: heartjnl-2022-320939. doi: 10.1136/heartjnl-2022-320939
    PubMed     Abstract available


    June 2022
  7. MARROQUIN L, Tirado-Conte G, Pracon R, Streb W, et al
    Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure.
    Heart. 2022;108:1098-1106.
    PubMed     Abstract available


    April 2022
  8. KOMEN J, Pottegard A, Hjemdahl P, Mantel-Teeuwisse AK, et al
    Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds.
    Heart. 2022;108:613-618.
    PubMed     Abstract available


  9. MORITA S, Malik AH, Kuno T, Ando T, et al
    Analysis of outcome of 6-month readmissions after percutaneous left atrial appendage occlusion.
    Heart. 2022;108:606-612.
    PubMed     Abstract available


  10. HOLT A, Blanche P, Zareini B, Rasmussen PV, et al
    Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants.
    Heart. 2022;108:626-632.
    PubMed     Abstract available


    March 2022
  11. RAATIKAINEN P, Lassila R
    COVID-19: another reason for anticoagulation in patients with atrial fibrillation.
    Heart. 2022 Mar 21. pii: heartjnl-2022-320845. doi: 10.1136/heartjnl-2022-320845
    PubMed    


  12. HANDY A, Banerjee A, Wood AM, Dale C, et al
    Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort.
    Heart. 2022 Mar 10. pii: heartjnl-2021-320325. doi: 10.1136/heartjnl-2021-320325
    PubMed     Abstract available


  13. BARBIELLINI AMIDEI C, Trevisan C, Dotto M, Ferroni E, et al
    Association of physical activity trajectories with major cardiovascular diseases in elderly people.
    Heart. 2022;108:360-366.
    PubMed     Abstract available


  14. WANG X, Dong JY, Cui R, Muraki I, et al
    Smoking cessation, weight gain and risk of cardiovascular disease.
    Heart. 2022;108:375-381.
    PubMed     Abstract available


    February 2022
  15. EVERS-DORPFELD S, Aeschbacher S, Hennings E, Eken C, et al
    Sex-specific differences in adverse outcome events among patients with atrial fibrillation.
    Heart. 2022 Feb 8. pii: heartjnl-2021-320122. doi: 10.1136/heartjnl-2021-320122.
    PubMed     Abstract available


  16. OTTO CM
    Heartbeat: bleeding risk in atrial fibrillation patients on non-vitamin K oral anticoagulant medications.
    Heart. 2022;108:243-245.
    PubMed    


    January 2022
  17. OTTO CM
    Heartbeat: sex disparities in stroke, heart failure and all-cause mortality in adults with coronary heart disease.
    Heart. 2022;108:1-3.
    PubMed    


    December 2021
  18. OTTO CM
    Heartbeat: lower risk of dementia with a direct oral anticoagulatant, compared to a vitamin K antagonist, for patients with atrial fibrillation.
    Heart. 2021;107:1847-1849.
    PubMed    


  19. FRAISSE A, Hascoet S, Kempny A
    Closing atrial septal defects for prevention of stroke: how small is too small?
    Heart. 2021;107:1850-1851.
    PubMed    


  20. DOLGNER SJ, Steinberg ZL, Jones TK, Reisman M, et al
    Stroke in patients with secundum atrial septal defect and sequelae after transcatheter closure.
    Heart. 2021;107:1875-1880.
    PubMed     Abstract available


    October 2021
  21. CADOGAN SL, Powell E, Wing K, Wong AY, et al
    Anticoagulant prescribing for atrial fibrillation and risk of incident dementia.
    Heart. 2021 Oct 13. pii: heartjnl-2021-319672. doi: 10.1136/heartjnl-2021-319672
    PubMed     Abstract available


  22. NADARAJAH R, Alsaeed E, Hurdus B, Aktaa S, et al
    Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis.
    Heart. 2021 Oct 4. pii: heartjnl-2021-320036. doi: 10.1136/heartjnl-2021-320036.
    PubMed     Abstract available


  23. ARORA GK, Kumar Gupta P, Bansal S
    Transient ischaemic attack in a young woman.
    Heart. 2021;107:1629-1682.
    PubMed    


    September 2021
  24. BARNETT-GRINESS O, Stein N, Kotler A, Saliba W, et al
    Novel bleeding prediction model in atrial fibrillation patients on new oral anticoagulants.
    Heart. 2021 Sep 21. pii: heartjnl-2021-319702. doi: 10.1136/heartjnl-2021-319702
    PubMed     Abstract available


    August 2021
  25. AKYEA RK, Kontopantelis E, Kai J, Weng SF, et al
    Sex disparity in subsequent outcomes in survivors of coronary heart disease.
    Heart. 2021 Aug 24. pii: heartjnl-2021-319566. doi: 10.1136/heartjnl-2021-319566
    PubMed     Abstract available


  26. SCHNABEL RB, Wallenhorst C, Engler D, Blankenberg S, et al
    Refined atrial fibrillation screening and cost-effectiveness in the German population.
    Heart. 2021 Aug 10. pii: heartjnl-2020-318882. doi: 10.1136/heartjnl-2020-318882
    PubMed     Abstract available


    July 2021
  27. FUKAYA H, Ako J, Yasuda S, Kaikita K, et al
    Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319321. doi: 10.1136/heartjnl-2021-319321
    PubMed     Abstract available


  28. PHILLIPS K, Subramanian A, Thomas GN, Khan N, et al
    Trends in the pharmacological management of atrial fibrillation in UK general practice 2008-2018.
    Heart. 2021 Jul 5. pii: heartjnl-2021-319338. doi: 10.1136/heartjnl-2021-319338.
    PubMed     Abstract available


    June 2021
  29. PARKER WA, Storey RF
    Antithrombotic therapy for patients with chronic coronary syndromes.
    Heart. 2021;107:925-933.
    PubMed    


  30. TAM DY, Rocha RV, Fang J, Ouzounian M, et al
    Multiple arterial coronary bypass grafting is associated with greater survival in women.
    Heart. 2021;107:888-894.
    PubMed     Abstract available


    May 2021
  31. DAGENAIS GR, Dyal L, Bosch JJ, Leong DP, et al
    Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease.
    Heart. 2021 May 21. pii: heartjnl-2020-318758. doi: 10.1136/heartjnl-2020-318758
    PubMed     Abstract available


  32. ELVAN A
    It's all about improvement of quality of life and reduction of disease burden in atrial fibrillation ablation.
    Heart. 2021 May 20. pii: heartjnl-2021-319382. doi: 10.1136/heartjnl-2021-319382
    PubMed    


  33. CHOI Y, Lee Y, Kim SH, Kim S, et al
    Single direct oral anticoagulant therapy in stable patients with atrial fibrillation beyond 1 year after coronary stent implantation.
    Heart. 2021 May 14. pii: heartjnl-2020-318750. doi: 10.1136/heartjnl-2020-318750
    PubMed     Abstract available


  34. RUTHERFORD OW, Jonasson C, Ghanima W, Soderdahl F, et al
    Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation.
    Heart. 2021 May 11. pii: heartjnl-2020-318753. doi: 10.1136/heartjnl-2020-318753
    PubMed     Abstract available


  35. PARK J, Yoon YE, Kim KM, Hwang IC, et al
    Prognostic value of lower bone mineral density in predicting adverse cardiovascular disease in Asian women.
    Heart. 2021 May 7. pii: heartjnl-2020-318764. doi: 10.1136/heartjnl-2020-318764.
    PubMed     Abstract available


  36. JOLOBE O
    Next frontier is inclusion of high-grade carotid artery stenosis in the CHA2DS2 Vasc score.
    Heart. 2021;107:767.
    PubMed    


  37. KARTHIKEYAN G
    Stroke risk in rheumatic heart disease.
    Heart. 2021;107:694-696.
    PubMed    


    April 2021
  38. BUCHAN TA, Malik A, Chan C, Chambers J, et al
    Predictive models for cardiovascular and kidney outcomes in patients with type 2 diabetes: systematic review and meta-analyses.
    Heart. 2021 Apr 8. pii: heartjnl-2021-319243. doi: 10.1136/heartjnl-2021-319243.
    PubMed     Abstract available


  39. SPARROW R, Sanjoy S, Choi YH, Elgendy IY, et al
    Racial, ethnic and socioeconomic disparities in patients undergoing left atrial appendage closure.
    Heart. 2021 Apr 1. pii: heartjnl-2020-318650. doi: 10.1136/heartjnl-2020-318650.
    PubMed     Abstract available


  40. SCOTT ML, Murnane KS, Orr AW
    Young at heart? Drugs of abuse cause early-onset cardiovascular disease in the young.
    Heart. 2021;107:604-606.
    PubMed    


  41. GEURINK K, Holmes D, Ezekowitz MD, Pieper K, et al
    Patterns of oral anticoagulation use with cardioversion in clinical practice.
    Heart. 2021;107:642-649.
    PubMed     Abstract available


    March 2021
  42. MELDUNI R, Nkomo VT, Wysokinski W, Gersh BJ, et al
    Risk of left atrial appendage thrombus and stroke in patients with atrial fibrillation and mitral regurgitation.
    Heart. 2021 Mar 25. pii: heartjnl-2020-317659. doi: 10.1136/heartjnl-2020-317659
    PubMed     Abstract available


  43. VENETSANOS D, Traff E, Erlinge D, Hagstrom E, et al
    Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention.
    Heart. 2021 Mar 12. pii: heartjnl-2020-318694. doi: 10.1136/heartjnl-2020-318694
    PubMed     Abstract available


    February 2021
  44. LOWRES N, Giskes K, Freedman B
    Next frontier in management of atrial fibrillation.
    Heart. 2021 Feb 23. pii: heartjnl-2021-318961. doi: 10.1136/heartjnl-2021-318961
    PubMed    


    January 2021
  45. BOSSARD M, Gao P, Boden W, Steg G, et al
    Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease.
    Heart. 2021 Jan 27. pii: heartjnl-2020-318045. doi: 10.1136/heartjnl-2020-318045
    PubMed     Abstract available


  46. MALLINSON PAC, Luhar S, Williamson E, Barreto ML, et al
    Socioeconomic position and cardiovascular mortality in 63 million adults from Brazil.
    Heart. 2021 Jan 22. pii: heartjnl-2020-318153. doi: 10.1136/heartjnl-2020-318153
    PubMed     Abstract available


  47. MARCUSCHAMER I, Zusman O, Iakobishvili Z, Assali AR, et al
    Outcome of patients with prior coronary bypass surgery admitted with an acute coronary syndrome.
    Heart. 2021 Jan 18. pii: heartjnl-2020-318047. doi: 10.1136/heartjnl-2020-318047
    PubMed     Abstract available


  48. MAZNYCZKA AM, McCartney P, Duklas P, McEntegart M, et al
    Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trial.
    Heart. 2021 Jan 12. pii: heartjnl-2020-317828. doi: 10.1136/heartjnl-2020-317828
    PubMed     Abstract available


  49. VASCONCELOS M, Vasconcelos L, Ribeiro V, Campos C, et al
    Incidence and predictors of stroke in patients with rheumatic heart disease.
    Heart. 2021 Jan 7. pii: heartjnl-2020-318054. doi: 10.1136/heartjnl-2020-318054.
    PubMed     Abstract available


  50. WU J, Mamas MA, Mohamed MO, Kwok CS, et al
    Place and causes of acute cardiovascular mortality during the COVID-19 pandemic.
    Heart. 2021;107:113-119.
    PubMed     Abstract available


  51. SINGH T, Newby DE
    Is the fear of disease worse than the disease itself?
    Heart. 2021;107:91-92.
    PubMed    


  52. OTTO CM
    Heartbeat: increased use of NOACs in patients with atrial fibrillation reduces health care system costs by reducing stroke incidence.
    Heart. 2021;107:1-3.
    PubMed    


    December 2020
  53. O' DONNELL M, Hankey GJ, Rangarajan S, Chin SL, et al
    Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level.
    Heart. 2020 Dec 14. pii: heartjnl-2019-316515. doi: 10.1136/heartjnl-2019-316515
    PubMed     Abstract available


  54. GARCIA RODRIGUEZ LA, Cea Soriano L, Munk Hald S, Hallas J, et al
    Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke.
    Heart. 2020 Dec 11. pii: heartjnl-2020-317887. doi: 10.1136/heartjnl-2020-317887
    PubMed     Abstract available


  55. HANON O, Vidal JS, Pisica-Donose G, Orvoen G, et al
    Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation.
    Heart. 2020 Dec 1. pii: heartjnl-2020-317923. doi: 10.1136/heartjnl-2020-317923.
    PubMed     Abstract available


    November 2020
  56. SANJOY S, Choi YH, Holmes D, Herrman H, et al
    Comorbidity burden in patients undergoing left atrial appendage closure.
    Heart. 2020 Nov 23. pii: heartjnl-2020-317741. doi: 10.1136/heartjnl-2020-317741
    PubMed     Abstract available


    October 2020
  57. SEIFFGE DJ, Meinel TR
    The real prize of direct oral anticoagulant blockbuster.
    Heart. 2020 Oct 28. pii: heartjnl-2020-318092. doi: 10.1136/heartjnl-2020-318092
    PubMed    


  58. ORLOWSKI A, Gale CP, Ashton R, Petrungaro B, et al
    Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation.
    Heart. 2020 Oct 28. pii: heartjnl-2020-317006. doi: 10.1136/heartjnl-2020-317006
    PubMed     Abstract available


  59. BARRA S, Providencia R
    Anticoagulation in atrial fibrillation.
    Heart. 2020 Oct 28. pii: heartjnl-2020-316728. doi: 10.1136/heartjnl-2020-316728
    PubMed    


  60. BOYLE PM, Del Alamo JC, Akoum N
    Fibrosis, atrial fibrillation and stroke: clinical updates and emerging mechanistic models.
    Heart. 2020 Oct 23. pii: heartjnl-2020-317455. doi: 10.1136/heartjnl-2020-317455
    PubMed     Abstract available


    August 2020
  61. HENDRIKS J, Gallagher C, Nyfort-Hansen K, Lau D, et al
    Adherence to anticoagulation therapy in patients with atrial fibrillation: is a tailored team-based approach warranted?
    Heart. 2020 Aug 7. pii: heartjnl-2020-317478. doi: 10.1136/heartjnl-2020-317478.
    PubMed    


    May 2020
  62. AL SAID S, Katus HA, Alabed S
    Cochrane corner: NOACs in atrial fibrillation patients post-percutaneous coronary intervention.
    Heart. 2020 May 29. pii: heartjnl-2020-316726. doi: 10.1136/heartjnl-2020-316726
    PubMed    


  63. BURDEN AF
    Tub bathing and heart disease.
    Heart. 2020;106:710.
    PubMed    


    April 2020
  64. SON MK, Park JJ, Lim NK, Kim WH, et al
    Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Heart. 2020 Apr 27. pii: heartjnl-2019-316219. doi: 10.1136/heartjnl-2019-316219
    PubMed     Abstract available


  65. CHATEAUNEUF G, Nazif TM, Beaupre F, Kodali S, et al
    Cerebrovascular events after transcatheter mitral valve interventions: a systematic review and meta-analysis.
    Heart. 2020 Apr 17. pii: heartjnl-2019-316331. doi: 10.1136/heartjnl-2019-316331
    PubMed     Abstract available


  66. OTTO CM
    Heartbeat: risk of stroke in patients with heart failure.
    Heart. 2020;106:549-551.
    PubMed    


    March 2020
  67. KRISAI P, Blum S, Aeschbacher S, Beer JH, et al
    Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.
    Heart. 2020 Mar 31. pii: heartjnl-2019-316314. doi: 10.1136/heartjnl-2019-316314
    PubMed     Abstract available


  68. UKAI T, Iso H, Yamagishi K, Saito I, et al
    Habitual tub bathing and risks of incident coronary heart disease and stroke.
    Heart. 2020 Mar 24. pii: heartjnl-2019-315752. doi: 10.1136/heartjnl-2019-315752
    PubMed     Abstract available


  69. YAO X, Noseworthy P
    NOAC dosing and monitoring: really as simple as it seems?
    Heart. 2020;106:321-322.
    PubMed    


    February 2020
  70. KIM JY, Kim SH, Myong JP, Choi Y, et al
    Ten-year trends in the incidence, treatment and outcomes of patients with mitral stenosis in Korea.
    Heart. 2020 Feb 6. pii: heartjnl-2019-315883. doi: 10.1136/heartjnl-2019-315883.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: